Notable companies reporting after the market close, with earnings consensus, include Vertex Pharmaceuticals (VRTX), consensus $4.02… Lattice ...
Pre-earnings options volume in Vertex is normal with calls leading puts 7:4. Implied volatility suggests the market is anticipating a move near ...
Vertex Pharmaceuticals (VRTX) reports Q4 earnings today. Investors are eager for updates on new drug launches and growth ...
Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $4.02 per share, down from $4.20 per share in the year-ago period. Vertex Pharmaceuticals projects quarterly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results